Biotricity, Inc. (BTCY)

Biotricity Balance Sheet

Financials in millions USD. Fiscal year is April - March.

Year	2023	2022	2021	2020	2019
Cash & Equivalents	0.79	0.57	12.15	2.2	0.95
Cash & Cash Equivalents	0.79	0.57	12.15	2.2	0.95
Cash Growth	37.79%	-95.31%	451.97%	131.78%	1392.37%
Receivables	1.62	1.32	2.01	1.57	0.53
Inventory	1.88	2.34	0.84	0.27	0.09
Other Current Assets	0.19	0.49	0.32	0.28	0.09
Total Current Assets	4.47	4.72	15.32	4.32	1.66
Property, Plant & Equipment	1.24	1.61	1.27	0.07	0.26
Other Long-Term Assets	0.23	0.18	0.09	0.05	0.08
Total Long-Term Assets	1.47	1.79	1.36	0.12	0.35
Total Assets	5.94	6.51	16.68	4.44	2
Accounts Payable	9.61	5.04	2.6	2.52	1.52
Current Debt	12.09	5.11	1.75	4.34	2.28
Other Current Liabilities	0.99	1.01	0.52	3.63	0
Total Current Liabilities	22.7	11.16	4.87	10.49	3.8
Long-Term Debt	11.78	14.44	13.6	0.37	0.06
Other Long-Term Liabilities	1.44	0.76	0.35	0.41	1.14
Total Long-Term Liabilities	13.22	15.2	13.96	0.78	1.2
Total Liabilities	35.92	26.36	18.82	11.27	5
Total Debt	23.88	19.55	15.35	4.71	2.34
Debt Growth	22.17%	27.31%	226.18%	101.30%	169.49%
Retained Earnings	-127.5	-112.57	-93.04	-62.82	-46.36
Comprehensive Income	0.03	-0.15	-0.77	-0.63	-0.86
Shareholders' Equity	-31.47	-19.85	-2.14	-6.83	-3
Net Cash / Debt	-23.09	-18.98	-3.2	-2.51	-1.39
Net Cash Per Share	-2.57	-2.19	-0.42	-0.40	-0.23
Working Capital	-18.23	-6.44	10.46	-6.17	-2.14
Book Value Per Share	-3.50	-2.29	-0.28	-1.09	-0.50

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).